| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 4,914,489 shares worth roughly $168.8M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.12B | - | |
| 10% | 34.49M | $1.25B | - | |
| Pres | 18.68M | $678.74M | - | |
| CEO | 16.74M | $608.19M | - | |
| Dir | 13.69M | $497.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Sell | 45,008,604 | $0.00 | - | -100% | |
| Dec 17, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 245,000 | $15.38 | $3,767,705.89 | +0.2% | |
| Dec 4, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 254,193 | $18.03 | $4,584,355.61 | +0.1% | |
| Nov 25, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 3,500,000 | $15.00 | $52,500,000.00 | +8.5% | |
| Nov 21, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 243,812 | $12.39 | $3,021,688.14 | +0.2% | |
| Jun 19, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 18,204 | $8.32 | $151,380.99 | - | |
| Jun 14, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 22,011 | $8.06 | $177,300.64 | - | |
| Jun 11, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 21,338 | $8.31 | $177,247.38 | - | |
| Jun 6, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 21,122 | $7.86 | $165,950.15 | - | |
| Jun 4, 2019 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 2,424,242 | $8.25 | $19,999,996.50 | +6.3% |